Evidence map›Paper›PMID 23481644›Full record

ReviewBioorganic & medicinal chemistry letters2013

The mammalian clock and chronopharmacology.

Kristine Griffett, Thomas P Burris

Open access · hybridAbstract readReview
In one paragraph

Review in Bioorganic & medicinal chemistry letters, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Nuclear receptor protein: REV-ERB.Northern clinics of Istanbul · 2025
    Review
  5. Article
  6. The role of REV-ERB in NASH.Acta pharmacologica Sinica · 2022
    Article
  7. Review
  8. Circadian rhythm as a therapeutic target.Nature reviews. Drug discovery · 2021
    Review
  9. Circadian Clock Regulates Inflammation and the Development of Neurodegeneration.Frontiers in cellular and infection microbiology · 2021
    Review
  10. Genetics of Circadian Rhythms.Neurologic clinics · 2019
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Spatiotemporal separation of PER and CRY posttranslational regulation in the mammalian circadian clock.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  16. Article
  17. Chronopharmacology of glucocorticoids.Advanced drug delivery reviews
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kristine Griffett130 Scripps Way 2A1, The Scripps Research Institute, Scripps Florida, Jupiter, FL 33458, USA.
Thomas P Burris
Scripps Research Institute · US

Funding

Development of ROR ligands for treatment of circadian rhythm disordersR01MH092769 · NIMH · ST. LOUIS COLLEGE OF PHARMACY · PI BURRIS, THOMAS P, WALKER, JOHN K. · 2011 to 2020
$6.1M
REV-ERB ligands for treatment of anxiety disordersR01MH093429 · NIMH · SCRIPPS FLORIDA · PI BURRIS, THOMAS P · 2012 to 2016
$3.6M
NIMH NIH HHS R01 MH092769NIMH NIH HHS R01 MH093429
6 · The paper itself

Abstract

Increases in our understanding of the molecular control of circadian rhythms and subsequent signaling pathways has allowed for new therapeutic drug targets to be identified as well as for a better understanding of how to more efficaciously and safely utilize current drugs. Here, we review recent advances in targeting components of the molecular clock in mammals for the development of novel therapeutics as well as describe the impact of the circadian rhythm on drug efficacy and toxicity.

Indexed as

Drug ChronotherapyAnimalsAntineoplastic AgentsCircadian ClocksCircadian RhythmHumansAntineoplastic Agents

Identifiers

PMID23481644
PMCPMC4864859
OpenAlexW2083023136

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.